Risk stratification of hepatocellular carcinoma after hepatitis C virus eradication in patients with compensated advanced chronic liver disease in Japan

Takuma Nakatsuka; Ryosuke Tateishi; Ryo Nakagomi; Tatsuya Minami; Kazuhiko Koike

doi:10.1016/j.jhep.2022.03.002

Risk stratification of hepatocellular carcinoma after hepatitis C virus eradication in patients with compensated advanced chronic liver disease in Japan

J Hepatol. 2022 Aug;77(2):569-571. doi: 10.1016/j.jhep.2022.03.002. Epub 2022 Mar 12.

Authors

Takuma Nakatsuka¹, Ryosuke Tateishi², Ryo Nakagomi³, Tatsuya Minami¹, Kazuhiko Koike³

Affiliations

¹ Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.
² Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. Electronic address: [email protected].
³ Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan; Department of Gastroenterology, Kanto Central Hospital of the Mutual Aid Association of Public School Teachers, 6-25-1 kamiyoga, Setagaya-ku, Tokyo 158-8531, Japan.

PMID: 35288188
DOI: 10.1016/j.jhep.2022.03.002

No abstract available

Keywords: Hepatitis C virus; Hepatocellular carcinoma; Liver stiffness measurement (LSM); Sustained virological response (SVR); compensated advanced chronic liver disease (cACLD).

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Antiviral Agents / therapeutic use
Carcinoma, Hepatocellular* / drug therapy
Carcinoma, Hepatocellular* / epidemiology
Carcinoma, Hepatocellular* / etiology
Hepacivirus / genetics
Hepatitis C* / drug therapy
Hepatitis C, Chronic* / complications
Hepatitis C, Chronic* / drug therapy
Hepatitis C, Chronic* / epidemiology
Humans
Japan / epidemiology
Liver Cirrhosis / pathology
Liver Neoplasms* / drug therapy
Liver Neoplasms* / epidemiology
Liver Neoplasms* / etiology
Risk Assessment
Sustained Virologic Response

Substances

Antiviral Agents